- Home
- DWTX
as 06-27-2025 12:31pm EST
Stocks
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | ALPHARETTA |
| Market Cap: | 9.2M | IPO Year: | N/A |
| Target Price: | $10.00 | AVG Volume (30 days): | 40.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -19.87 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.62 - $29.28 | Next Earning Date: | 08-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest DOGWOOD THERAPEUTICS INC News
DWTX Breaking Stock News: Dive into DWTX Ticker-Specific Updates for Smart Investing
ACCESS Newswire
18 days ago
Sidoti Events, LLC's Virtual June Small-Cap Conference
GlobeNewswire
25 days ago
Dogwood Therapeutics to Present at Sidoti Small-Cap Virtual Conference
Zacks Small Cap Research
2 months ago
DWTX: Phase 2b Trial in Chemotherapy Induced Neuropathic Pain Underway…
GlobeNewswire
2 months ago
Dogwood Therapeutics Announces First Quarter 2025 Financial Results
Newsfile
2 months ago
Dogwood Therapeutics, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference
GlobeNewswire
3 months ago
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance
Zacks Small Cap Research
3 months ago
DWTX: Interim Data for Phase 2b Trial in 4Q25…
GlobeNewswire
3 months ago
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance
Compare DWTX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DWTX DOGWOOD THERAPEUTICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.